Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay

BJU Int. 2019 Jul;124(1):35-39. doi: 10.1111/bju.14686. Epub 2019 Feb 20.

¹ Department of Radiation Oncology, Leuven University Hospital, Leuven, Belgium.
² Department of Urology, Leuven University Hospital, Leuven, Belgium.
³ Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
⁴ Department of Urology, San Raffaele Hospital, Milan, Italy.
⁵ Department of Radiation Oncology, San Raffaele Hospital, Milan, Italy.
⁶ Department of Urology, Ghent University Hospital, Ghent, Belgium.
⁷ Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
⁸ Olivia Newton John Cancer Centre, Melbourne, Vic., Australia.
⁹ Royal Marsden NHS Foundation Trust, London, UK.
¹⁰ Department of Radiation Oncology, Dana-Farber Cancer Institute, Bringham and Women's Hospital, Boston, MA, USA.
¹¹ Department of Radiology, Ghent University Hospital, Ghent, Belgium.
¹² Department of Oncology, Ghent Maria Middelares Hospital, Ghent, Belgium.
¹³ Department of Molecular Imaging, Pathology, Radiotherapy and Oncology, (MIPRO) Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.
¹⁴ Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.

No abstract available

Keywords: radiotherapy; stage I seminoma; testicular cancer.

Publication types